Cita APA

Bayona Cebada, A., Nattero Chávez, M. L., Alonso Díaz, S., Escobar Morreale, H. F., & Luque Ramírez, M. (2019). Efficacy and safety of SGLT2 inhibitors in Type 1 Diabetes after the introduction of an off-label use protocol for clinical practice.

Citación estilo Chicago

Bayona Cebada, Ane, María Lia Nattero Chávez, Sara Alonso Díaz, Héctor Francisco|||0000-0002-6890-1644 Escobar Morreale, y Manuel Luque Ramírez. Efficacy and Safety of SGLT2 Inhibitors in Type 1 Diabetes After the Introduction of an Off-label Use Protocol for Clinical Practice. 2019.

Cita MLA

Bayona Cebada, Ane, et al. Efficacy and Safety of SGLT2 Inhibitors in Type 1 Diabetes After the Introduction of an Off-label Use Protocol for Clinical Practice. 2019.